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The mechanisms by which IFN-g activates expres-
sion of interferon-stimulated genes that have
inflammatory and host defense functions are well un-
derstood. In contrast, little is known about how IFN-g
represses gene expression. By using transcriptomic
and epigenomic analysis, we found that stable
repression of a small group of genes by IFN-g is
associated with recruitment of the histone methyl-
transferase EZH2 and deposition of the negative
mark histone 3 lysine 27 trimethylation (H3K27me3)
at their promoters. Repressed genes included
MERTK, PPARG, and RANK, which have anti-inflam-
matory functions and promote osteoclast differentia-
tion. Gene repression and H3K27me3 persisted after
IFN-g signaling was terminated, and these silenced
genes were no longer responsive to glucocorticoids,
IL-4, and M-CSF. These results identify cytokine-
induced H3K27 trimethylation as a mechanism that
stabilizes gene silencing in macrophages. IFN-g-
induced macrophage activation is thus reinforced
by a chromatin-based mechanism that blocks anti-
inflammatory and opposing pathways.
INTRODUCTION
Interferon-gamma (IFN-g) is a key activator of macrophages that
induces expression of chemokines and antigen-presenting mol-
ecules and primes macrophages for enhanced microbial killing
and increased inflammatory cytokine production in response to
infectious or inflammatory challenges (Hu and Ivashkiv, 2009).
Mechanisms by which IFN-g activates the Jak-STAT pathway
to induce expression of interferon-stimulated genes (ISGs) via
binding of STAT1 to promoters and enhancers are well under-
stood (Stark andDarnell, 2012). Since the early days of transcrip-Cell Report
This is an open access article under the CC BY-Ntional profiling, it has been apparent that IFN-g also represses
gene expression (Ramana et al., 2001; Stark and Darnell,
2012). In contrast to gene activation, little is known about the
role of repression in macrophage biology, and about repressive
mechanisms. To date, mechanistic explanations of suppression
of gene expression by IFN-g mostly have been limited to inhibi-
tion of upstream signaling pathways required to induce gene
expression (Hu and Ivashkiv, 2009), and mechanisms underlying
direct repression of target genes by IFN-g have not been
elucidated.
Gene repression is mediated by multi-subunit corepressor
complexes, negative histone marks, and methylated CpG DNA
motifs (Glass and Saijo, 2010). Corepressor complexes are re-
cruited to genes by DNA-binding repressors and contain sub-
units with enzymatic activity that suppress gene expression by
erasing positive histone marks (histone deacetylases, HDACs;
histone demethylases), depositing negative histone marks
such as H3K9me3 and H3K27me3, and remodeling nucleo-
somes to close chromatin at regulatory elements. Many histone
marks and remodeling of nucleosomes are regulated in a dy-
namic manner by chromatin regulators with opposing enzymatic
activities. Thus, although chromatin-mediated mechanisms can
stabilize gene expression to confer ‘‘short-term transcriptional
memory’’ (Monticelli and Natoli, 2013), chromatin marks can
be erased within minutes and are thus reversible by environ-
mental stimuli. However, the two negative histone marks
H3K9me3 and H3K27me3 can be long-lived and stably silence
gene expression (Chen and Dent, 2014; Margueron and Rein-
berg, 2011). H3K9me3 is deposited in areas of heterochromatin
that are stably silenced in differentiated cells and maintains
repression of retro-elements. H3K27me3 is deposited by Poly-
comb Repressive Complex (PRC) 2, which is comprised of the
histone methyltransferase EZH2 (and in some cell types EZH1),
SUZ12, Eed, and the DNA-interacting protein JARID2. PRC2
has been extensively studied in early development, X chromo-
some inactivation, stem cell pluripotency and differentiation,
and cell transformation and is generally considered to promote
proliferation and function as an oncogene. Little is known abouts 16, 3121–3129, September 20, 2016 ª 2016 The Author(s). 3121
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Regulation of H3K27 Modification
by IFN-g Correlates with Gene Expression
(A–D) Freshly isolated human monocytes were
cultured with M-CSF (10 ng/ml) with or without
IFN-g (100 U/ml) for 24 hr. The genome-wide
profiles of H3K27Ac and H3K27me3 were as-
sessed by ChIP-seq, and gene expression was
measured by RNA-seq.
(A) Venn diagram showing the overlap (green
shading) of H3K27Ac and H3K27me3 peaks in
resting monocytes.
(B) Expression levels of genes in FPKM with pro-
moters marked by H3K27Ac alone, both H3K27Ac
and H3K27me3, or H3K27me3 alone in resting
human monocytes. Mean FPKM values from two
biological replicates are shown.
(C) Pie chart showing IFN-g-induced changes in
H3K27Ac and H3K27me3 read density sorted into
five bins, which correspond to the indicated
quantitative changes in read density.
(D) Correlation between histone modifications and
gene expression in IFN-g response. Expression of
genes with greater than 2-fold changes in pro-
moter-associated H3K27me3 or H3K27Ac levels
(‘‘> 2’’ and ‘‘< 0.5’’ bins in Figure 1C) is depicted.
Statistical analysis was performed using a paired
t test.the role of PRC2 in terminally differentiated non-proliferating
cells and in cells of the immune system.
In this study, we investigated whether IFN-g can suppress
gene expression by chromatin-mediated mechanisms, and
whether repression of anti-inflammatory genes contributes to
IFN-g-mediated macrophage activation. To maximize physio-
logical relevance for human inflammatory conditions, we used
primary human monocytes and macrophages that play a key
role in human inflammatory diseases. We found that IFN-g stably
silences a small group of genes including MERTK, PPARG, and
RANK; gene silencing is stabilized bymaintenance of H3K27me3
on gene promoters. IFN-g treatment made these genes refrac-
tory to activation by the inducers glucocorticoids, IL-4, and
M-CSF, respectively. These results identify a mechanism of sta-
ble gene repression by IFN-g. As PPARG andMERTK have anti-
inflammatory functions (Rothlin et al., 2015; Straus and Glass,
2007) and RANK is essential for differentiation down a non-in-3122 Cell Reports 16, 3121–3129, September 20, 2016flammatory pathway toward osteoclasts
(Guerrini and Takayanagi, 2014), these
findings suggest that one component of
macrophage activation by IFN-g is epige-
netic silencing of select anti-inflammatory
pathways.
RESULTS
IFN-g Regulates H3K27
Modification to Repress Gene
Expression
Modification of H3K27 plays a key role in
regulation of gene expression; acetylation(H3K27Ac) is associated with gene expression, and trimethyla-
tion (H3K27me3) is associated with gene silencing (Chen and
Dent, 2014). To test whether IFN-g could repress gene expres-
sion by decreasing H3K27Ac or increasing H3K27me3, we per-
formed chromatin immunoprecipitation sequencing (ChIP-seq)
experiments to measure regulation of these marks genome-
wide in primary human macrophages, and correlated changes
in H3K27 marks with changes in gene expression that were
measured by RNA sequencing (RNA-seq). We analyzed ChIP-
seq data using ChIPseeqer and HOMER (Escoubet-Lozach
et al., 2011; Giannopoulou and Elemento, 2011) to detect
H3K27Ac- and H3K27me3-enriched regions (peaks) (Figure S1).
A small subset of 3,000 loci exhibited both H3K27Ac and
H3K27me3 marks (termed bivalent loci) that were enriched in
promoters (Figures 1A and S1B, bottom; Figure S1C). As
expected (Chen and Dent, 2014), genes with promoter-associ-
ated H3K27Ac, but not with H3K27me3, showed the highest
expression; genes with bivalent promoters were expressed
at intermediate levels, and genes with promoter-associated
K27me3, but not H3K27Ac, were minimally expressed (Fig-
ure 1B). These results corroborate previous findings in other
cell types (Chen and Dent, 2014) and support the validity of our
ChIP-seq data and approach in primary human macrophages.
Next, we investigated the relationship between IFN-g-induced
H3K27 modification and IFN-g-mediated gene expression. In
accord with our recent report (Qiao et al., 2013), stimulation
with IFN-g for 24h resulted in a minimal (4%) change in the total
number of H3K27Ac peaks (Figure S1A), but in pervasive
changes in H3K27Ac read density: H3K27Ac levels changed in
49% of peaks, and approximately 60% of these peaks under-
went more than two fold changes in H3K27Ac read density (Fig-
ure 1C). In sharp contrast, only 6% of H3K27me3 peaks were
modulated by IFN-g; H3K27me3 read density was increased
by >2-fold at only 1.2% and decreased by >2-fold at 0.1% of
peaks (Figure 1C). Thus, regulation of H3K27me3 by IFN-g was
focused on a relatively small number of gene loci. IFN-g-medi-
ated regulation of H3K27 marks at gene promoters correlated
highly significantly with gene expression (Figure 1D). These re-
sults show a genome-wide correlation of IFN-g-mediated mod-
ulation of H3K27 marks at promoters and gene expression,
and suggest changes in H3K27 marks may regulate the IFN-g
response in human macrophages.
IFN-g Induces H3K27me3 at Promoters of Select Anti-
inflammatory Genes
IFN-gwas previously shown to regulate histone acetylation (Qiao
et al., 2013; Stark and Darnell, 2012) via STAT-associated his-
tone acetyltransferases, and thus we focused on the finding of
H3K27me3 regulation. To evaluate the functional significance
of H3K27me3 modulation in the IFN-g response, we analyzed
the functional characteristics of the genes regulated by this
mark. This analysis identified a small group of 20 genes whose
promoters demonstrated a greater than 2-fold increase
H3K27me3 after IFN-g treatment. 15 of these genes were ex-
pressed at baseline, and expression of 13 out of these 15 genes
decreased after IFN-g stimulation (Figure 2A). Another small
group of 20 genes showed >2-fold decreasedH3K27me3 at their
promoters and increased expression after IFN-g stimulation
(Table S1). Modulation of H3K27me3 in more distal regulatory
elements was less clearly associated with gene expression
and thus we focused on promoters and their immediately down-
stream genes. Strikingly, the genes whose downregulation by
IFN-g was associated with increased promoter H3K27me3
included genes with clear anti-inflammatory functions: MERTK
(mediates efferocytosis) (Rothlin et al., 2015), PPARG (sup-
presses inflammatory gene expression) (Straus and Glass,
2007; Vats et al., 2006), and TNFRSF11A (hereafter termed
RANK; the key mediator of differentiation down the alternative
osteoclast differentiation pathway that is associated with sup-
pressed inflammatory responses) (Guerrini and Takayanagi,
2014; Mochizuki et al., 2006). We focused on regulation of
MERTK, PPARG, and RANK.
We confirmed the IFN-g-induced H3K27me3 accumulation at
MERTK, PPARG, and RANK promoters by using ChIP-qPCR
(Figure 2B); conversely, and as specificity control, IFN-g induceddepletion of H3K27me3 at the promoters of SOCS1 and ETV7
genes that were robustly induced by IFN-g (Figure 2B). As a
negative control, H3K27me3 was not detected at the TNF pro-
moter regulated by distinct mechanisms (Ramirez-Carrozzi
et al., 2006). Repression ofMERTK, PPARG, and RANK expres-
sion was confirmed by qPCR (Figure 2C), as was repression of
additional genes (Figure S2A). Furthermore, IFN-g treatment re-
sulted in decreased occupancy of RNA polymerase II (Pol II) at
these gene promoters (Figure 2D). Gene tracks showing
H3K27Ac and H3K27me3 peaks at the MERTK, PPARG, and
RANK promoters are shown in Figure 2E. IFN-g treatment re-
sulted in H3K27me3 accumulation at all three promoters, without
any loss of H3K27Ac at MERTK or PPARG promoters. The
SOCS1 and ETV7 genes that were induced by IFN-g (Figure 2F)
exhibited the converse pattern of decreased H3K27me3 after
IFN-g treatment (Figure 2E).
Next, we investigated the kinetics of IFN-g-induced gene
downregulation to address whether genes are first induced
and then silenced or whether they are always targeted for
silencing. Analysis of MERTK, PPARG, and RANK mRNA after
1, 3, 6, 24, and 48 hr of IFN-g stimulation revealed no evidence
for early gene induction and instead showed downregulation
that was first observed at 3 hr and increased progressively
over time (Figure 2C). Downregulation of PPARG mRNA
occurred with slower kinetics than MERTK or RANK mRNA.
Because stability of mRNA transcripts could obscure decreases
in transcription at early time points, we also measured primary
unspliced transcripts that more directly reflect transcription.
Strikingly, MERTK and RANK primary transcripts were substan-
tially decreased after only 1 hr of IFN-g treatment, whereas
PPARG primary transcripts were downregulated with slower ki-
netics (Figure S2B), in accord with slower kinetics of mRNA
downregulation. Examination of all 13 genes that were downre-
gulated concurrent with H3K27me3 accumulation (Figure 2A) re-
vealed that 11/13 genes were progressively downregulated over
time, while PLTP andSPRED1were transiently induced and sub-
sequently downregulated (Figure S2C). We were surprised by
the rapid decrease in transcription and investigated the kinetics
of H3K27me3 accumulation. After IFN-g stimulation, increased
H3K27me3 was detected at 6 and 24 hr at the RANK promoter,
but not until 24 hr at the MERTK and PPARG promoters (Fig-
ure S2D). These results suggest that a distinct mechanism sup-
presses gene expression at early time points, while deposition of
H3K27me3 at later time points could serve to stabilize repression
or to make genes refractory to inducing stimuli.
IFN-g Regulates EZH2 Recruitment to Select Gene
Promoters
The regulation of H3K27me3 by cytokines has not been previ-
ously appreciated and could be mediated by changes in EZH2
that deposit this mark or the demethylases JmjD3 and ultra-
thorax (UTX) that erase it (Chen and Dent, 2014; Margueron
and Reinberg, 2011). We did not detect changes in expression
of mRNAs encoding these proteins and thus examined EZH2
recruitment to gene promoters. Strikingly, IFN-g induced recruit-
ment of EZH2 to MERTK, PPARG and RANK promoters, while
decreasing EZH2 occupancy at SOCS1 and ETV7 promoters
(Figure 3A). EZH2-containing PRC2 can cooperatively functionCell Reports 16, 3121–3129, September 20, 2016 3123
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Figure 2. IFN-g Induces H3K27me3 at Promoters of Select Anti-inflammatory Genes Whose Expression Is Downregulated
(A) Heatmap of gene expression (left) andH3K27me3 read density (right) of 13 geneswhose promoters showed a >2-fold increase in H3K27me3 associatedwith a
decrease in gene expression.
(B) Confirmation of H3K27me3 regulation using ChIP-qPCR with primers for the TSS region of the indicated genes.
(C) Confirmation of gene expression by qPCR.
(D) Regulation of RNA polymerase II occupancy by ChIP-qPCR. In (B) and (D) IFN-g-induced differences were statistically significant (p < 0.05, one-tailed t test),
except for HBB, for pooled data from independent experiments.
(E) Read density for H3K27me3 and H3K27Ac at the indicated genes in control or IFN-g-treated macrophages. Gene tracks were visualized using the UCSC
genome browser.
(F) Confirmation of gene expression by qPCR. Data are representative of two (A and E) or at least three (B–D and F) experiments.
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Figure 3. IFN-g Induces EZH2 Recruitment
and Associated Gene Silencing
(A and B) ChIP-qPCR analysis of occupancy of
EZH2 (A) and H2A-K119Ub (B) at the indicated
gene promoters after IFN-g stimulation. In (A) and
(B), IFN-g-induced differences were statistically
significant (p < 0.05, paired t test), except for TNF,
for pooled data from independent experiments.
(C) LNA-mediated suppression of EZH2 mRNA
(bar graphs on the left) and protein (western blot on
the right).
(D) RANK expression after EZH2 knockdown. Cells
were cultured with IFN-g for 3 days and then
stimulated withM-CSF (100 ng/ml) for 3 hr. Results
are representatives of at least three experiments.with PRC1 to silence gene expression; EZH2-deposited
H3K27me3 recruits PRC1, which adds another repressive his-
tone mark H2AK119-Ub to further stabilize and reinforce gene
repression (Schwartz and Pirrotta, 2013). Consistent with this
model, H2AK119-Ub was increased at promoters of genes with
increasedEZH2 andH3K27me3 anddecreased at genes that ex-
hibited lower EZH2 and H3K27me3 after IFN-g stimulation (Fig-
ure 3B). To test the causal role of EZH2 in IFN-g-mediated gene
repression, we knocked down EZH2 expression using antisense
locked nucleic acids (LNAs) (Figure 3C). Substantial knockdownCell Reportsof EZH2 (approximately 80% under IFN-
g-stimulated conditions) did not reverse
IFN-g-mediated suppression of RANK
(Figure 3D, bar 5 versus bar 6) or of
PPARG orMERTK (Figure S3A). These re-
sults are consistent with distinct and
redundant IFN-g-activated suppressive
mechanisms, possibly related to the early
phase suppression described above (Fig-
ures S2B–S2D). We then considered the
possibility that, instead of inducing sup-
pression, the role of EZH2 could be to sta-
bilize the repressed state andmake genes
with high H3K27me3 resistant to induc-
tion by M2-related cytokines. Supportive
of this notion, EZH2 knockdown resulted
in increased RANK induction by M-CSF
under IFN-g-stimulated conditions (Fig-
ure 3D, bar 7 versus bar 8). However,
similar induction of PPARG under IFN-g-
repressed conditions was not observed,
and induction of MERTK was not consis-
tently observed in all donors when EZH2
was knocked down (Figure S3A). We ob-
tained similar results using the EZH inhib-
itor UNC1999 (Figure S3B), although in
this case UNC1999 treatment resulted in
increased induction by IL-10 of the IFN-
g-silenced gene HSTST1 but did not
broadly reverse gene suppression (Fig-
ure S3C; data not shown). It is possible
that these gene-specific results couldbe related to incomplete knockdown or inhibition of EZH2, the
function of the distinct early-acting suppressive pathway, or
stabilization of repression by H2AK119-Ub (Figure 3B). Collec-
tively, the results suggest that there are likely other players and
several repressive pathways that are partially redundant that
work together to suppress gene expression.
IFN-g Stably Silences Gene Expression
Macrophage phenotypes are generally considered to be plastic
and reversible in response to environmental cues (Gosselin et al.,16, 3121–3129, September 20, 2016 3125
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2014; Ivashkiv, 2013; Lavin et al., 2014; Okabe and Medzhitov,
2014), and an important question is whether IFN-g induces
stable changes in macrophage gene expression that are resis-
tant to changes in the environment. We therefore tested the
stability of IFN-g-induced H3K27me3 and gene repression in hu-
man macrophages, and whether genes silenced by this mecha-
nism became refractory to induction by cytokines that oppose
IFN-g functionally. First, we found that repression of MERTK,
PPARG and RANK and the concomitant increase in promoter
H3K27me3 was maintained for at least 4 days after addition of
one dose of IFN-g (Figures 4A and 4B), even though canonical
IFN-g-Jak-STAT1 signaling mostly resolves after 2 days (Hu
et al., 2005). To further address the question of whether IFN-g-
induced chromatin changes persist after the IFN-g signal is
terminated, we washed out IFN-g after one day of stimulation.
IFN-g-induced H3K27me3 at MERTK, PPARG and RANK pro-
moters persisted without any detectable decrease for at least
3 days after wash out of IFN-g (Figure 4C; data not shown).
This stability of H3K27me3 was likely explained, at least in
part, by maintenance of EZH2 occupancy (Figure S3D). We
then tested whether IFN-g-mediated silencing made genes
refractory to activation by their major inducers. MERTK,
PPARG, and RANK were activated by the glucocorticoid dexa-
methasone (dex), IL-4, and M-CSF, respectively (Figure 4D,
bar 3 versus bar 1). IFN-g-induced repression of these genes
was not reversed by dex, IL-4, or M-CSF (Figure 4D, bar 4 versus
bar 3), which was in accord with maintained high levels of
H3K27me3 at these gene promoters (Figure 4E). Similar results
were obtained when IFN-g was washed out for 2 days prior to
challenge with dex, IL-4, or M-CSF (Figure 4F). Collectively,
these results show that IFN-g induces stable H3K27me3 chro-
matin marks that persist well after IFN-g signaling, which meets
one definition of an epigenetic mechanism (Monticelli and Natoli,
2013), and that genes silenced by this stable mechanism are re-
fractory to induction by opposing cytokines.
DISCUSSION
In contrast to gene induction in IFN-g-mediated macrophage
activation, the mechanisms and functions of gene repression in
IFN-g responses are poorly understood. In this study, we identi-
fied IFN-g-induced recruitment of EZH2 and associated deposi-
tion of the negative histone mark H3K27me3 as a mechanism by
which IFN-g silences gene expression in macrophages. Gene
silencing associated with EZH2-H3K27me3was stable, resistant
to challenge by opposing cytokines, and abrogated the expres-
sion of a small group of genes with anti-inflammatory functions.Figure 4. IFN-g Stably Induces H3K27me3 and Makes Genes Refracto
(A) qPCR analysis of the indicated mRNAs, normalized relative to GAPDH, durin
(B) ChIP-qPCR analysis of H3K27me3 during a time course of IFN-g stimulation
(p < 0.05, paired t test) for pooled data from three independent experiments.
(C) ChIP-qPCR analysis of H3K27me3 in macrophages cultured without IFN-g (co
24 hr, followed by a 24 hr washout period (column 3).
(D) qPCR analysis of mRNA in macrophages cultured with or without IFN-g (100 U
(E) ChIP-qPCR analysis of H3K27me3 inmacrophages culturedwith or without IFN
the indicated factors for 3 hr.
(F) qPCR analysis of the indicated mRNAs normalized relative to GAPDH. Macro
representative of at least three experiments (A–F).Our findings support amodel in which IFN-g engages chromatin-
based epigenetic mechanisms to silence select anti-inflamma-
tory pathways in macrophages to achieve and stabilize an
activated state.
Previous work analyzing gene repression by cytokines impli-
cated competition between opposing STATs or recruitment of
the Sin3a corepressor complex (Hu and Ivashkiv, 2009; Icardi
et al., 2012). We identify a distinct mechanism whereby IFN-g in-
duces recruitment of a different repressor complex containing
the histone methylase EZH2. EZH2 has been previously
described to bind to and silence expression of the IFN-g-induc-
ible gene CIITA in uveal melanoma cells, where knockdown of
EZH2 resulted in increased IFN-g inducibility of CIITA (Holling
et al., 2007); induction of EZH2 occupancy and H3K27 deposi-
tion by IFN-g has not been previously described. The highly
selective recruitment of EZH2 to a small group of gene pro-
moters suggests a specific mechanism that will be investigated
in future work.
A kinetic analysis revealed that IFN-g rapidly suppresses gene
transcription, prior to deposition of H3K27me3. This indicates
that IFN-g engages additional mechanisms to induce the initial
suppression of the group of target genes where it increases
levels of H3K27me3 at a later time point. One possible mecha-
nism is decreased histone acetylation, but it is likely that there
are additional suppressivemechanisms at play. These additional
mechanisms are sufficient to induce gene suppression, as
knockdown or inhibition of EZH2 did not prevent IFN-g-medi-
ated gene suppression. Our results suggest that instead of
inducing gene suppression, IFN-g-mediated increases in
H3K27me3 work together with other repressive mechanisms to
stabilize gene silencing over time, and to make genes refractory
to induction by opposing M2 cytokines. Such cooperative func-
tion of mechanisms to silence gene expression is in accord with
the literature (Schwartz and Pirrotta, 2013).
The functional significance of IFN-g-mediated gene repres-
sion for IFN-g-induced macrophage activation has not been
clarified. Our results suggest that one component of IFN-g-
mediated macrophage activation is H3K27me3-associated sta-
ble silencing of genes, such as MERTK and PPARG, that could
otherwise promote deactivation of macrophages by opposing
or anti-inflammatory environmental factors. Refractoriness of
MERTK and PPARG to induction by glucocorticoids and IL-4
compromises the ability of these factors to deactivate macro-
phages in the face of IFN-g stimulation. One important function
of IFN-g is to suppress osteoclast differentiation and limit
bone resorption in inflammatory settings (Takayanagi et al.,
2000). RANK is a key nonredundant receptor required forry to Induction
g a time course of IFN-g stimulation.
. For (A) and (B), differences between 0 and other time points were significant
lumn 1), with IFN-g (100 U/ml) for 24 hr (column 2), or with IFN-g (100 U/ml) for
/ml) for 24 hr and then stimulated with dex, IL-4 (50 ng/ml), or M-CSF for 3 hr.
-g for 24 hr. IFN-gwas then removed, and 24 hr later, cells were stimulatedwith
phages were cultured as in (E), except the washout period was 48 hr. Data are
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osteoclastogenesis and silencing of RANK to make cells refrac-
tory to its ligand RANKL will limit bone erosion (Ji et al., 2009;
Lorenzo et al., 2008). Thus, our findings suggest an important
role for IFN-g in stably diverting myeloid precursors from the
osteoclast differentiation pathway, which limits bone damage
and simultaneously enables cells to polarize in an M1 direction
important for host defense.
Our work highlights the importance of gene repression in
IFN-g-mediated macrophage activation. IFN-g silencing of a
small number of anti-inflammatory genes was stabilized via
H3K27me3 deposition at their promoters; this can make genes
resistant to induction by environmental cues. Future work is
needed to identify additional mechanisms of gene repression
by IFN-g and how they relate tomacrophage functions important
in inflammation and host defense.
EXPERIMENTAL PROCEDURES
Cell Culture
CD14+ human monocytes were purified from peripheral blood mononuclear
cells (PBMCs) by positive selection using anti-CD14 magnetic beads (Miltenyi
Biotec 130-050-201) using a protocol approved by the Hospital for Special
Surgery Institutional Review Board. Monocytes were cultured in RPMI 1640
medium (Invitrogen, cat # 11875119) supplemented with 10% fetal bovine
serum (FBS) (HyClone Fisher, cat # SH30031.02) and 10 ng/ml M-CSF; Pepro-
tech, cat # 300-25).
ChIP and ChIP-Seq
ChIP was performed as previously described (Qiao et al., 2013). For regular
ChIP asssays, immunoprecipitated DNA was analyzed by quantitative real-
time PCR and normalized relative to input DNA amount. For ChIP-seq exper-
iments, more than 100 million nonclonal mapped tags were obtained for each
condition in each experiment and analyzed using ChIPseeqer (Giannopoulou
and Elemento, 2011). Peak calling was normalized to input DNA sequencing
data with p < 1015, fold induction > 2, with FDR < 0.025 for all datasets.
Two biological replicates were performed, and scatter plots and Pearson cor-
relation coefficients between peak heights in biological replicates are shown in
the Supplemental Experimental Procedures.
RNA-Seq
Sequencing libraries were prepared using TruSeq RNA Library Preparation
Kits (Illumina), and more than 40 million non-clonal reads were obtained for
each sample. TopHat was used for alignment and Cufflinks was used for
gene differential expression analysis.
Western Blotting
Cytoplasmic, nuclear, or whole-cell extracts were fractionated on 7.5%–10%
polyacrylamide gels by SDS-PAGE, transferred to polyvinylidene fluoride
membranes (Millipore), and incubated with specific antibodies; enhanced
chemiluminescence (Amersham) was used for detection.
Quantitative Real-Time PCR
Total RNA was extracted with the RNeasy Mini Kit (QIAGEN) and reverse tran-
scribed using the First Strand cDNA Synthesis kit (Fermentas). Quantitative
real-time PCR was performed in triplicate using an ABI7500 thermal cycler.
Primer sequences are provided in the supplemental materials (Tables S2
and S3).
RNA Interference
EZH2 gene knockdown was achieved by transfecting monocytes with LNA
oligonucleotides (anti-EZH2: 300600, design ID: 322973-1; control: 300610)
from Exiqon using an Amaxa Nucleofector (Lonza) and the Nucleofector Kit
for Human Monocytes (Lonza) in accordance with the manufacturer’s
protocol.3128 Cell Reports 16, 3121–3129, September 20, 2016Statistical Analysis
Statistical analyses were performed using a one-tailed t test or one-way
ANOVA as indicated.
ACCESSION NUMBERS
The accession number for the genomic data utilized in this study is GEO:
GSE84692.
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